Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector

Proc Natl Acad Sci U S A. 1987 Oct;84(19):6854-8. doi: 10.1073/pnas.84.19.6854.

Abstract

We have constructed a vaccinia virus recombinant that expresses the extracellular domain of the rat neu oncogene-encoded protein, a 185-kDa transmembrane glycoprotein termed p185. Strain NFS mice immunized with this recombinant virus developed a strong antibody response against the neu oncogene product and were fully protected against subsequent tumor challenge with neu-transformed NIH 3T3 cells. No tumor immunoprotection was found when recombinant virus-immunized mice were challenged with Ha-ras-transformed NIH 3T3 cells. These data indicate that immunization with a single oncogene-encoded antigen can fully and specifically protect animals against tumor cells bearing this antigen.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibody Formation
  • Cell Line
  • Cell Transformation, Neoplastic*
  • Cells, Cultured
  • Enzyme-Linked Immunosorbent Assay
  • Genetic Vectors
  • Haplotypes
  • Immunotherapy*
  • Mice
  • Mice, Inbred Strains
  • Neoplasms, Experimental / immunology
  • Neoplasms, Experimental / therapy*
  • Oncogenes*
  • Rats
  • Vaccinia virus / genetics*
  • Vaccinia virus / immunology